ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TRADJENTA
Diabetes
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

REMOVE SELECTED | COMPARE SELECTED

Drug Name:

TRADJENTA Rx

TRADJENTA (linagliptin) 5mg tablets by Boehringer Ingelheim and Eli Lilly

Generic Name and Formulations:
Linagliptin 5mg; tabs.

Company:
Boehringer Ingelheim and Lilly

e-Prescribe this drug via Surescripts


Therapeutic Use:

Product Resources »
  • Product Information
  • Coupons, Samples & Vouchers
  • Patient Education and Assistance

Indications for TRADJENTA:

Adjunct to diet and exercise in type 2 diabetes mellitus, as monotherapy or combination therapy.

Adult Dose for TRADJENTA:

5mg once daily.

Children's Dose for TRADJENTA:

Not recommended.

Pharmacological Class:

Dipeptidyl peptidase-4 inhibitor.

Warnings/Precautions:

Not for the treatment of type 1 diabetes or diabetic ketoacidosis. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Antagonized by strong P-gp or CYP3A4 inducers (eg, rifampin); consider alternatives to linagliptin if used in combination. May need lower dose of concomitant sulfonylurea or insulin to reduce risk of hypoglycemia.

Adverse Reactions:

Nasopharyngitis, hypoglycemia, arthralgia, back pain, headache; hypersensitivity reactions (eg, urticaria, angioedema, localized skin exfoliation, bronchial hyperreactivity), myalgia, pancreatitis.

Metabolism:

Extensively unchanged.

Elimination:

Enterohepatic (80%), renal (5%).

Generic Availability:

NO

How Supplied:

Tabs—30, 90, 1000